# Retracted: Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Carcinoma: A Real-World Study

**Authors:** BioMed Research International

PMC · DOI: 10.1155/2024/9785671 · BioMed Research International · 2024-03-20

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** Breast Carcinoma (MESH:D001943)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10977187/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10977187/full.md

---
Source: https://tomesphere.com/paper/PMC10977187